Sarcoid-Like Granulomatosis Induced by Nivolumab Treatment in a Lung Cancer Patient
Nivolumab, an anti-PD-1 antibody, inhibits binding between PD-1 and PD-1 ligand and activates antigen-specific T cells that have become unresponsive to cancer cells. Although it is recommended as a second-line therapy in gene mutation-negative non-small-cell lung cancer, interstitial pneumonia is a...
Na minha lista:
| Principais autores: | , , , , , , , |
|---|---|
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
Karger Publishers
2018-08-01
|
| coleção: | Case Reports in Oncology |
| Assuntos: | |
| Acesso em linha: | https://www.karger.com/Article/FullText/492383 |
| Tags: |
Sem tags, seja o primeiro a adicionar uma tag!
|